eureKARE seeks disruptive synthetic biology solutions to tackle environmental and sustainability challenges
03 juil. 2023 08h37 HE | EUREKARE
The 2nd edition of the eurekAWARDS is launched! Luxembourg, Belgium, Monaco, and Paris, France – 3 July 2023: eureKARE, a pioneering company focused on financing and building next generation...
TelesisBio_Logo_RGB.png
Telesis Bio to Present at Jefferies Healthcare Conference 2023
08 juin 2023 09h05 HE | Telesis Bio
SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, announced that Todd R. Nelson, Ph.D., CEO and Founder...
Synlogic_Logo_Blue.png
Synlogic Reminds Stockholders of 2023 Annual General Meeting Details
08 juin 2023 06h45 HE | Synlogic, Inc.
CAMBRIDGE, Mass., June 08, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today reminded stockholders that it will...
Synlogic_Logo_Blue.png
Synlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference
24 mai 2023 06h35 HE | Synlogic, Inc.
CAMBRIDGE, Mass., May 24, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced its planned presentations at...
TelesisBio_Logo_RGB.png
Telesis Bio to Present at SynBioBeta 2023
23 mai 2023 09h00 HE | Telesis Bio
SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their benchtop...
Synlogic_Logo_Blue.png
Synlogic to Present at the Jefferies Global Healthcare Conference
23 mai 2023 06h50 HE | Synlogic, Inc.
CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that Aoife Brennan, M.B....
TelesisBio_Logo_RGB.png
Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
22 mai 2023 12h00 HE | Telesis Bio
SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its...
TelesisBio_Logo_RGB.png
Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
18 mai 2023 10h00 HE | Telesis Bio
SAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its...
SynBioBeta.jpg
Synthetic Biology Industry Raises $US10.3 Billion in 2022 with Largest Investments in Synbio Applications, Bio-CAD, and Gene Synthesis and Sequencing with Strong Growth Expected
18 mai 2023 09h05 HE | SynBioBeta
SAN FRANCISCO, May 18, 2023 (GLOBE NEWSWIRE) -- After record-setting investment peaks in FY 2020 and 2021 for synthetic biology, the field raised $10.3 billion in 2022. While this is still a...
MRW.png
Synthetic Biology Market Size 2023 To 2030 | A Comprehensive Analysis Has Been Provided, With A Detailed Competitive Landscape Examination and Projected CAGR Value of 22.0%.
15 mai 2023 06h09 HE | Market Reports World
Pune, May 15, 2023 (GLOBE NEWSWIRE) -- Global Synthetic Biology Market [2023-2030] Research Report Analysis and Outlook Insights | Latest Updated Report | 115 Pages Report | The Synthetic Biology...